RESI Conference, New York November 2017, 37 pages Deal and Product Valuations
Category: Presentations
BIO IP & Diagnostics Symposium (IPDx) Keynote Session
Dr. Patrik Frei was the keynote speaker at BIO IP & Diagnostics Symposium (IPDx) on 29th of September 2017. During the session, the Venture Valuation CEO discussed the valuation of biotechnology companies and products and its link to IP. He gave a short introduction to risk-adjusted net present value calculations, the main value drivers and … Continue reading BIO IP & Diagnostics Symposium (IPDx) Keynote Session
Valuation Workshop at RESI Conference – Boston, September 2017
During the last RESI (Redefining Early Stage Investments) Conference – the event series organized by Life Science Nation, a Venture Valuation long-time partner – Dr. Patrik Fried delivered a session on life science deal and product valuations. The notes from the workshop are available to download here
Assessing the Valuation of New Ventures – MassChallengeCH, Lausanne, September 2017
Venture Valuation CEO, Dr. Patrik Frei is one of the experts working as mentors for MassChallengeCH, a famous startup accelerator. He helps new entrepreneurs understand the concepts and meaning of company valuation. Below, you can find a link to the notes from his workshop about assessing a company prior to valuation. Assessing the Valuation of New … Continue reading Assessing the Valuation of New Ventures – MassChallengeCH, Lausanne, September 2017
Valuation of Life Sciences Start-up – Questions and Answers
Last month, CEO of Venture Valuation, Dr Patrik Frei, delivered a live webinar titled ‘Valuation of Life Sciences Start-up’ to healthcare alumni of Harvard Business School You can watch the webinar here. Due to a large number of questions from participants, not all of them could be answered during the event. In this post, we … Continue reading Valuation of Life Sciences Start-up – Questions and Answers
Dr. Patrik Frei Delivers a Webinar to Harvard Business School Alumni
On 7th of June 2017, CEO of Venture Valuation, Dr Patrik Frei, delivered a live webinar titled ‘Valuation of Life Sciences Start-up’ to healthcare alumni of Harvard Business School. The online event was a part of Healthcare Roundtable, a series of interactive presentations by industry leaders organised by HBS Healthcare Alumni Association. Dr. Frei talked about the significance … Continue reading Dr. Patrik Frei Delivers a Webinar to Harvard Business School Alumni
RESI Conference June 2017- Deal and Product Valuations Workshop
Dr. Patrik Frei, Venture Valuation CEO and a worldwide known expert in life sciences company and product valuation, delivered a workshop on the topic during he Redefining Early Stage Investments Conference in San Diego. The notes from the workshop are available to download here.
Panel at JPM January 2017 – Future of Life Sciences
The topic if this year’s evening event at JPM in San Francisco co-organized by BaselArea.swiss Economic Promotion, KPMG and Venture Valuation was Designing The Future in Life Sciences – A Discussion About (Human) Capital & Innovation. How will life sciences look like in – let’s say – 2030? What are sustainable and future business models for biotech … Continue reading Panel at JPM January 2017 – Future of Life Sciences
Valuation and HealthTech in Asia
RESI Conference, San Francisco January 2017, 23 pages Valuation and HealthTech in Asia, RESI (Jan 2017)